Esperion Therapeutics
NASDAQ: ESPR
Healthcare
Drug Manufacturers - Specialty & Generic
Rank
#20581
Market Cap
174.38 M
Volume
2.04 M
Price
0.88
Change (%)
1.84%
Country or region
United States
United States
Esperion Therapeutics's latest marketcap:
174.38 M
As of 05/20/2025, Esperion Therapeutics's market capitalization has reached $174.38 M. According to our data, Esperion Therapeutics is the 20581th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 174.38 M |
| Revenue (ttm) | 259.57 M |
| Net Income (ttm) | -153,222,000 |
| Shares Out | 198.20 M |
| EPS (ttm) | -0.81 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/06/2025 |
Market Cap Chart
Data Updated: 05/20/2025
Esperion Therapeutics's yearly market capitalization.
Esperion Therapeutics has seen its market value drop from $211 M to $174.38 M since 2013, representing a total decrease of 17.36% and an annual compound decline rate (CAGR) of 1.66%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 05/20/2025 | $174.38 M | -63.51% |
| 12/31/2024 | $433.50 M | 27.5% |
| 12/29/2023 | $340 M | -25.93% |
| 12/30/2022 | $459 M | 215.68% |
| 12/31/2021 | $145.40 M | -79.94% |
| 12/31/2020 | $724.80 M | -55.52% |
| 12/31/2019 | $1.63 B | 32.13% |
| 12/31/2018 | $1.23 B | -28.5% |
| 12/29/2017 | $1.72 B | 510.8% |
| 12/30/2016 | $282.40 M | -43.67% |
| 12/31/2015 | $501.30 M | -39.08% |
| 12/31/2014 | $822.90 M | 290% |
| 12/31/2013 | $211 M |
Company Profile
Frequently Asked Questions
As of 05/20/2025, Esperion Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $174.38 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Esperion Therapeutics global market capitalization ranking is approximately 20581 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | United States |
| Founded | 2008 |
| IPO Date | 06/26/2013 |
| Employees | 304 |
| CEO | |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Address | |
| Website |
